RT Journal Article
SR Electronic
T1 The Build-Up of Aerosols Carrying the SARS-CoV-2 Coronavirus, in Poorly Ventilated, Confined Spaces
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.11.20173195
DO 10.1101/2020.08.11.20173195
A1 Birnir, Björn
YR 2020
UL http://medrxiv.org/content/early/2020/11/25/2020.08.11.20173195.abstract
AB A model of the distribution of respiratory droplets and aerosols by Lagrangian turbulent air-flow is developed and used to show how the SARS-CoV-2 Coronavirus can be dispersed by the breathing of an infected person. It is shown that the concentration of viruses in the exhaled cloud can increase to infectious levels with time (grow linearly), in a confined space where the air re-circulates. The model is used to analyze the air-flow and SARS-CoV-2 Coronavirus build-up in a restaurant in Guangzhou, China [30, 28]. It is concluded that the outbreak of Covid-19 pandemic in the restaurant in January 2020, is due to the build-up of the airborne droplets and aerosols carrying the SARS-CoV-2 Coronavirus and would not have been prevented by standard ventilation. A comparison with standard models for aerosol concentration shows that, in the absence of ventilation, the decay of the aerosol concentration is also controlled by the decay time of the virions in aerosols. This decay time is very long and a steady state is not achieved in the time-frame of the contagion. Instead the concentration exhibits a polynomial increase and reaches infectious levels in a relatively short time, explaining the outbreak in the restaurant in Guangzhou.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NoneAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is included